Polymorphism within the tumor necrosis factor α (TNF) promoter region in patients with ankylosing spondylitis

Human Immunology

Volumn 60, Issue 2, 1999, Pages 140-144

  Kaijzel, Eric L ^a   Brinkman, Brigitta M N ^a   Van Krugten, Michiel V ^a   Smith, Louise ^a   Huizinga, Tom W J ^a   Verjans, Georges M G M ^a   Breedveld, Ferdinand C ^a   Verweij, Cornelis L ^a  

^a NONE

Author keywords

Ankylosing spondylitis; Gene polymorphism; HLA B27; Tumor necrosis factor

Indexed keywords

HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032957276     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00099-8     Document Type: Article

References (33)

1. Brewerton D., Hart F., Nicholls A., Caffrey M., James D., Sturrock R. Ankylosing spondylitis and HLA-B27. Lancet. i:1990;904.
2. + patients. Arthritis Rheum. 32:1989;1135.
3. + patients. Arthritis Rheum. 32:1989;1135.
4. Verjans G.M.G.M., Messer G., Weiss E.H., van der Linden S.M., Kijlstra A. Polymorphism of the tumor necrosis factor region in relation to disease an overview . Rheumatic Disease Clinics of North America. 18:(1):1992;177.
5. Verjans G.M.G.M., Brinkman B.M.N., Van Doornik C.E.M., Kijlstra A., Verweij C.L. Polymorphism of tumour necrosis factor-alpha (TNF-α) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol. 97:1994;45.
6. Campbell D.R., Trowsdale J. Map of the human histocompatibility complex. Immunol Today. 14:1993;349.
7. Sklatvala J. Tumor necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 322:1986;547.
8. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α relevance to genetic predisposition to systemic lupus erythematosus . Proc Natl Acad of Sci USA. 87:1990;1233.
9. Hamann A., Mantzoros C., Vidal-Puig A., Flier J.S. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Com. 211:(3):1995;833.
10. Wilson A.G., de Vries N., Pociot F., Di Giovine F.S., van der Putte L.B.A., Duff G.W. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 177:1993;557.
11. D'Alfonso S., Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 39:1994;150.
12. McGuire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508.
13. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., Blackwell J.M. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 182:(5):1995;1259.
14. Pociot F., Wilson A.G., Nerup J., Duff G.W. No independent association between a tumor necrosis factor-α promoter region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol. 23:1993;3043.
15. Wilson A.G., Gordon C., Di Giovine F.S., De Vries N., Van de Putte L.B.A., Emery P., Duff G.W. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol. 24:1994;191.
16. Brinkman B.M.N., Huizinga T.W.J., Kurban S.S., van de Velde E.A., Schreuder G.M.T., Hazes J.M.H., Breedveld F.C., Verweij C.L. Tumour necrosis factor α gene polymorphisms in rheumatoid arthritis association with susceptibility to, or severity of, disease? Br J Rheum. 36:1997;516.
17. Vinasco J., Beraun Y., Nieto A., Fraile A., Maratan L., Pareja E., Martin J. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens. 49:1997;74.
18. Huizinga T.W.J., Westendorp R.G.J., Bollen E.L.E.M., Keijsers V., Brinkman B.M.N., Langermans J.A.M., Breedveld F.C., Verweij C.L., Van de Gaer L., Dams L., Crusius J.B.A., Garcia-Gonzalez A., Van Oosten B.W., Polman C.H., Pena A.S. TNF-α polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 72:1997;149.
19. D'Alfonso S., Colombo G., Della Bella S., Scorza R., Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens. 47:1996;551.
20. Höhler T., Kruger A., Schneider P.M., Schopf R.E., Knop J., Rittner C., Meyer zum Büschenfelde K-H M., ärker-Hermann E. A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol. 109:1997;562.
21. Moll J., Wright V. New York clinical criteria for ankylosing spondylitis a statistical evaluation . Ann Rheum Dis. 32:1973;354.
22. Schreuder G.M.T., Hendriks G.F.J., D'Amaro J., Persijn G.G. An eight-year study of HLA-typing proficiency in Eurotransplant. Tissue Antigens. 27:1986;131.
23. Verduyn W., Doxiadis I., Anholts J., Drabbels J., Naipal A., D'Amaro J., Persijn G., Giphart M., Schreuder G. Biotinylated DRB sequence-specific oligonucleotides Comparison by serological HLA-DR typing of organ donors in Eurotransplant . Hum Immunol. 35:1993;59.
24. Fleiss J.L. Statistical methods for rates and proportions. 1981;J Wiley and Sons, New York.
25. Mattiuz P.L., Ihde D., Piazza A., Ceppelini R., Bodmer W.F. New approaches to the population genetic and segregation analysis of the HLA-system. Terasaki P.I. Histocompatibility testing. 1970;Munksgaard, Copenhagen.
26. Brown M., Wordsworth P. Predisposing factors to spondyloarthropathies. Curr Opin Rheumatol. 9:1997;308.
27. Siegert S., Yin Z., Grolms M., Rudwaleit M., Radbruch A., Sieper J., Braun J. Evidence for differences in cytokine secretion by peripheral blood cells (PBC) of HLA B27-positive vs. -negative healthy controls. Clin Exp Rheumatol. 16:(2):1998;215.
28. Fraile A., Nieto A., Beraun Y., Vinasco J., Mataran L., Martin J. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens. 51:1998;386.
29. Conway D.J., Holland M.J., Bailey R.L., Campbell A.E., Mahdi O.S.M., Jennings R., Mbena E., Mabey D.C.W. Scarring Trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infection Immunity. 65:(3):1997;1003.
30. Grove J., Daly A.K., Bassendine M.F., Day C.P. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 26:1997;143.
31. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA. 94:1997;3195.
32. Brinkman B.M.N., Zuijdgeest D., Kaijzel E.L., Breedveld F.C., Verweij C.L. Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFa gene regulation. J Inflam. 46:1996;32.
33. Stüber F., Udalova I.A., Book M., Drutskaya L.N., Kuprash D.V., Turetskaya R.L., Schade F.U., Nedospasov S.A. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflam. 46:1996;42.